Fibrodysplasia (myositis) ossificans progressiva: Clinicopathological features and natural history

QJM: An International Journal of Medicine

Volumn 89, Issue 6, 1996, Pages 445-456

  Smith, R ^a   Athanasou, N A ^a   Vipond, S E ^a  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACK MUSCLE; CERVICAL SPINE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EXOSTOSIS; FEMALE; FIBROMATOSIS; HALLUX; HIP; HISTOLOGY; HUMAN; INFANT; JAW; JOINT; LONG BONE; MALE; METAPHYSIS; NECK MUSCLE; OSSIFICATION; OSSIFYING MYOSITIS; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; SKELETAL MUSCLE; SOFT TISSUE SARCOMA; THUMB; TOE; TREATMENT FAILURE;

EID: 0029971889     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.6.445     Document Type: Article

References (29)

1. Connor JM. Fibrodysplasia ossificans progressiva. In PM Royce, B Steinmann, eds. Connective Tissue And Its Heritable Disorders, 1st edn. Wiley Liss, 1993.
2. Connor J, Evans DAP. Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg 1982; 64B:76-83.
3. Cohen RB, Hahn GV, Tabas JA, Peeper J, Levitz CL, Sando A, Danso N, Zasloff M, Kaplan FS. The natural history of heterotopic ossification of patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 1993; 75A:215-19.
4. Kaplan FS, Tabas JA, Zasloff MA. Fibrodysplasia ossificans progressiva: A clue from the fly? Calc Tissue Int 1990; 47:117-25.
5. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Development 1994; 8:133-46.
6. Kingsley DM. What do BMPs do in mammals? Clues from the mouse short-ear mutation. TIG 1994; 10:16-21.
7. Shafritz A, Gannon F, Mitchell H, Zasloff M, Meunke M, Shore E, Kaplan F. Disregulation of bone morphogenetic protein (BMP-4) gene expression in fibrodysplasia ossificans progressiva (FOP). ASBMR abstract. J Bone Miner Res 1995; 10(Suppl):S191.
8. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age-and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthopaed Related Res 1994; 301:243r-8.
9. Kaplan FS, Tabas JA, Gannon FHH, Finkel G, Hanhn GV, Zasloff MA. The histopathology of fibrodysplasia ossificans progressiva. J Bone Joint Surg 1993; 75A:220-30.
10. Connor JM, Skirton H, Lunt PW. A three generation family with fibrodysplasia ossificans progressiva. J Med Genet 1993; 30:687-9.
11. Kaplan FS, McCluskey W, Hahn G, Tabas JA, Muenke M, Zasloff MA. Genetic transmission of fibrodysplasia ossificans progressiva. J Bone Joint Surg 1993; 75A:1214-20.
12. Smith R. Myositis ossificans progressiva: a review of current problems. Semin Arthritis Rheum 1975; 4:369-80.
13. Smith R, Russell RCG, Woods CG. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment. J Bone Joint Surg 1976; 58B:48-57.
14. Smith R. Fibrodysplasia ossificans progressiva. Twenty-six patients followed for up to twenty years. Bone 1994; 15:242-3 (Abstract).
15. Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS. Permanent hetrotopic ossification at the injection site after diphtheria-tetanus-pertussus immunisations in children who have fibrodysplasia ossificans progressiva. J Pediat 1995; 126:762-4.
16. Schroeder HW, Zasloff M. The hand and foot malformations in fibrodysplasia ossificans progressiva. Johns Hopkins Med J 1980; 147:73-8.
17. Guidera KJ. Genetic conditions. In Drennan JC, ed. The Child's Foot and Ankle, 1st edn. New York, Raven Press, 1992.
18. Connor JM, Smith R. The cervical spine in fibrodysplasia ossificans progressiva. Br J Radiol 1982; 55:492-6.
19. O'Reilly M, Renton P. Metaphyseal abnormalities in fibrodysplasia ossificans progressiva. Br J Radiol 1993; 66:112-6.
20. Tabas JA, Zasloff M, Fallon MD, Gannon FH, Cohen RB, Kaplan FS. Enchondroma in a patient with fibrodysplasia ossificans progressiva. Clin Orthopaed 1993; 294:277-80.
21. Kalifa G, Adamsbaum C, Job-Deslande C, Dubousse TJ. Fibrodysplasia ossificans progressiva and synovial chondromatosis. Paediat Radiol 1993; 23:91-3.
22. Pazzaglia U, Beluffie G, Ravelli A, Zatti G, Martini A. Chronic intoxication by ethane-1-hydroxy-1, 1 diphosphonate (EHDP) in a child with myositis ossificans progressiva. Paediat Radiol 1993; 23:439-62.
23. Bridges AJ, Kou-Ching H, Singh A, Churchill R, Miles J. Fibrodysplasia (Myositis) ossificans progressiva. Semin Arthritis Rheum 1994; 24:155-64.
24. Enzinger FM, Weiss SW. Soft tissue tumours. St Louis, USA, Mosby, 1995.
25. Winnier G, Blessing M, Labosky PL, Hogan BL. Bone morphogenetic protein is required for mesoderm formation and patterning in the mouse. Genes Development 1995; 9:2105-16.
26. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y, Oikawa S, Ono K, Takaoka K. Transient and localised expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994; 9:651-9.
27. Johnson RL, Riddle RD, Tabin CJ. Mechanisms of limb patterning. Curr Opin Genet Development 1994; 4:535-42.
28. Storn EE, Huynh TV, Copeland NC, Jenkins NA, Kingsley DM, Se-Jin L. Limb alterations in brachypodism mice due to mutations in a new member of the TGF β-super family. Nature 1994; 368:639-42.
29. Proceedings of The Second International Symposium On Fibrodysplasia Ossificans Progressiva. University of Pennsylvania School of Medicine. 29-31 Oct 1995. Calc Tissue Int (in press).